Machina Capital S.A.S. acquired a new stake in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) during the 3rd quarter, Holdings Channel.com reports. The fund acquired 9,221 shares of the company’s stock, valued at approximately $619,000.
A number of other large investors also recently bought and sold shares of DOCU. Illinois Municipal Retirement Fund increased its holdings in shares of Docusign by 15.1% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 133,488 shares of the company’s stock valued at $8,964,000 after acquiring an additional 17,464 shares during the last quarter. Lido Advisors LLC raised its position in shares of Docusign by 20.6% during the 3rd quarter. Lido Advisors LLC now owns 10,479 shares of the company’s stock valued at $704,000 after acquiring an additional 1,791 shares in the last quarter. New York Life Investment Management LLC raised its position in shares of Docusign by 15.0% during the 3rd quarter. New York Life Investment Management LLC now owns 30,368 shares of the company’s stock valued at $2,039,000 after acquiring an additional 3,951 shares in the last quarter. AlphaCore Capital LLC lifted its stake in Docusign by 35.1% during the third quarter. AlphaCore Capital LLC now owns 9,416 shares of the company’s stock worth $632,000 after purchasing an additional 2,445 shares during the last quarter. Finally, Fulcrum Asset Management LLP lifted its stake in Docusign by 64,697.0% during the third quarter. Fulcrum Asset Management LLP now owns 43,414 shares of the company’s stock worth $2,908,000 after purchasing an additional 43,347 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.
Docusign Price Performance
Shares of NASDAQ DOCU opened at $80.76 on Monday. The firm has a market capitalization of $15.09 billion, a PE ratio of 49.24, a P/E/G ratio of 2.97 and a beta of 0.80. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $85.90. The business’s fifty day moving average price is $74.01 and its two-hundred day moving average price is $55.80.
Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.07. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The company had revenue of $875.75 million during the quarter, compared to the consensus estimate of $867.22 million. During the same quarter in the previous year, the company posted $0.30 earnings per share. The company’s revenue for the quarter was up 9.4% compared to the same quarter last year. Equities research analysts expect that Docusign Inc. will post 2.15 earnings per share for the current fiscal year.
Analyst Ratings Changes
DOCU has been the subject of a number of research reports. UBS Group lifted their price objective on shares of Docusign from $54.00 to $70.00 and gave the stock a “neutral” rating in a report on Friday, September 4th. Royal Bank Of Canada increased their target price on shares of Docusign from $55.00 to $70.00 and gave the stock a “sector perform” rating in a report on Friday, September 4th. Bank of America raised their price target on shares of Docusign from $58.00 to $64.00 and gave the stock an “underperform” rating in a research report on Friday, September 4th. Wells Fargo & Company boosted their price objective on shares of Docusign from $55.00 to $60.00 and gave the company an “equal weight” rating in a research report on Friday, September 4th. Finally, Wall Street Zen lowered shares of Docusign from a “strong-buy” rating to a “buy” rating in a research note on Sunday, August 2nd. Three equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $67.62.
View Our Latest Analysis on Docusign
Insiders Place Their Bets
In related news, CEO Allan Thygesen sold 26,250 shares of Docusign stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $69.29, for a total value of $1,818,862.50. Following the sale, the chief executive officer directly owned 166,801 shares in the company, valued at $11,557,641.29. This trade represents a 13.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mary Wilderotter sold 1,000 shares of the business’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $68.80, for a total transaction of $68,800.00. Following the transaction, the director directly owned 2,199 shares of the company’s stock, valued at $151,291.20. The trade was a 31.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 154,168 shares of company stock worth $10,491,896. 0.59% of the stock is owned by company insiders.
Docusign Company Profile
DocuSign, Inc. provides software for preparing, signing, managing and automating agreements. Its platform helps businesses and individuals complete agreements digitally, reducing reliance on paper-based processes. The company’s offerings include DocuSign eSignature, which enables users to sign and request signatures electronically, as well as tools for contract lifecycle management and agreement workflows. Its Intelligent Agreement Management products use artificial intelligence to help organizations analyze and manage agreement-related information and processes.
Read More
- Five stocks we like better than Docusign
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
